198 related articles for article (PubMed ID: 30193961)
21. In silico identification of microRNAs as candidate colorectal cancer biomarkers.
Fadaka AO; Klein A; Pretorius A
Tumour Biol; 2019 Nov; 41(11):1010428319883721. PubMed ID: 31718480
[TBL] [Abstract][Full Text] [Related]
22. Integrative analyses of molecular pathways and key candidate biomarkers associated with colorectal cancer.
Pirim D
Cancer Biomark; 2020; 27(4):555-568. PubMed ID: 32176635
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.
Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B
Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition.
Muto Y; Suzuki K; Kato T; Tsujinaka S; Ichida K; Takayama Y; Fukui T; Kakizawa N; Watanabe F; Saito M; Futsuhara K; Noda H; Miyakura Y; Konishi F; Rikiyama T
Int J Oncol; 2016 Sep; 49(3):1057-67. PubMed ID: 27315529
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
Liu J; Li J; Li H; Li A; Liu B; Han L
Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
[TBL] [Abstract][Full Text] [Related]
26. Functional Prediction of Candidate MicroRNAs for CRC Management Using in Silico Approach.
Fadaka AO; Pretorius A; Klein A
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635135
[TBL] [Abstract][Full Text] [Related]
27. [Construction of a PCR chip for detecting genes associated with metastatic colorectal cancer and its preliminary application].
Xiao XQ; Tang N; Liu C; Wang HX; Jiang Q; Deng YJ; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1169-74. PubMed ID: 21764687
[TBL] [Abstract][Full Text] [Related]
28. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
[TBL] [Abstract][Full Text] [Related]
29. Integrated analysis of gene expression signatures associated with colon cancer from three datasets.
Gao P; He M; Zhang C; Geng C
Gene; 2018 May; 654():95-102. PubMed ID: 29408621
[TBL] [Abstract][Full Text] [Related]
30. Increased LEF1 expression and decreased Notch2 expression are strong predictors of poor outcomes in colorectal cancer patients.
Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Ruan ZP; Tian T; Guo H; Wang SH; Nan KJ
Dis Markers; 2013; 35(5):395-405. PubMed ID: 24223455
[TBL] [Abstract][Full Text] [Related]
31. Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data.
Jung Y; Lee S; Choi HS; Kim SN; Lee E; Shin Y; Seo J; Kim B; Jung Y; Kim WK; Chun HK; Lee WY; Kim J
Clin Cancer Res; 2011 Feb; 17(4):700-9. PubMed ID: 21304002
[TBL] [Abstract][Full Text] [Related]
32. Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical Analysis.
Guo Y; Bao Y; Ma M; Yang W
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350360
[TBL] [Abstract][Full Text] [Related]
33. Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.
Hata T; Mokutani Y; Takahashi H; Inoue A; Munakata K; Nagata K; Haraguchi N; Nishimura J; Hata T; Matsuda C; Murata K; Mizushima T; Doki Y; Mori M; Yamamoto H
Int J Oncol; 2017 Feb; 50(2):487-496. PubMed ID: 28000854
[TBL] [Abstract][Full Text] [Related]
34. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
35. Identification of Common Genes Refers to Colorectal Carcinogenesis with Paired Cancer and Noncancer Samples.
Zhang L; Yang Y; Cheng L; Cheng Y; Zhou HH; Tan ZR
Dis Markers; 2018; 2018():3452739. PubMed ID: 29651323
[TBL] [Abstract][Full Text] [Related]
36. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
[TBL] [Abstract][Full Text] [Related]
37. Transcriptomics-based screening of molecular signatures associated with patients overall survival and their key regulators in subtypes of breast cancer.
Eskandari E; Motalebzadeh J
Cancer Genet; 2019 Nov; 239():62-74. PubMed ID: 31569063
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF.
Mosakhani N; Lahti L; Borze I; Karjalainen-Lindsberg ML; Sundström J; Ristamäki R; Osterlund P; Knuutila S; Sarhadi VK
Cancer Genet; 2012 Nov; 205(11):545-51. PubMed ID: 23098991
[TBL] [Abstract][Full Text] [Related]
39. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
40. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
